Correlation Between Transcode Therapeutics and SeqLL
Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and SeqLL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and SeqLL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transcode Therapeutics and SeqLL Inc, you can compare the effects of market volatilities on Transcode Therapeutics and SeqLL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of SeqLL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and SeqLL.
Diversification Opportunities for Transcode Therapeutics and SeqLL
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Transcode and SeqLL is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and SeqLL Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SeqLL Inc and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with SeqLL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SeqLL Inc has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and SeqLL go up and down completely randomly.
Pair Corralation between Transcode Therapeutics and SeqLL
If you would invest (100.00) in SeqLL Inc on January 17, 2025 and sell it today you would earn a total of 100.00 from holding SeqLL Inc or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Transcode Therapeutics vs. SeqLL Inc
Performance |
| Timeline |
| Transcode Therapeutics |
| SeqLL Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Transcode Therapeutics and SeqLL Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Transcode Therapeutics and SeqLL
The main advantage of trading using opposite Transcode Therapeutics and SeqLL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, SeqLL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SeqLL will offset losses from the drop in SeqLL's long position.| Transcode Therapeutics vs. Xenetic Biosciences | ||
| Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | ||
| Transcode Therapeutics vs. Eyenovia | ||
| Transcode Therapeutics vs. Cognition Therapeutics |
| SeqLL vs. Agilent Technologies | ||
| SeqLL vs. iSpecimen | ||
| SeqLL vs. Intelligent Bio Solutions | ||
| SeqLL vs. bioAffinity Technologies, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |